NABL, CAP, ISO
EPO is a hormone produced in the kidneys that regulates red cell production. The levels vary inversely with hematocrit. This assay is useful as an aid in distinguishing between primary and secondary Polycythemia. It also differentiates between appropriate secondary Polycythemia (High altitude, pulmonary disease, tobacco use) and inappropriate secondary Polycythemia (tumors). The assay helps to identify candidates for EPO replacement therapy (Chronic renal failure). The assay evaluates patients undergoing EPO replacement therapy who demonstrate inadequate hematopoeitic response
- No special preparation required
Diagno Labs, established in the year 2012, is uniquely positioned to more effectively support local pathology for enhanced patient care. Diagno Labs, with complementary areas of expertise and service offerings, allows us to build on the company's leadership positions, provide access to medical and scientific expertise, expand geographical presence to better serve customers and emerge as the most valued company in the healthcare industry. Our Parent group RJ Corp is a well-diversified Indian MNC,with an annual turnover of over 15 billion rupees. Established in the 1990s, RJ Corp has achieved heights of success under the dynamic leadership and guidance of its founder-chairman Mr. Ravi Kant Jaipuria. The group has diversified business interests in beverages, breweries, real estate, hospitality, healthcare, education, dairy, food service and retail. Our network company, Cryobanks International India, is a leader in the collection, processing and banking of umbilical cord blood stem cells.
Available at Other Labs